NewLink Genetics Corp (NASDAQ:NLNK)

21.18
Data as of Jul 31
 -1.64 / -7.19%
Today’s Change
15.61
Today|||52-Week Range
53.48
-3.77%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$636.1M

Company Description

NewLink Genetics Corp. is a biopharmaceutical company focused on discovering, developing and commercializing novel immunotherapeutic products to improve cancer treatment options for patients and physicians. Its portfolio includes biologic and small molecule immunotherapy product candidates intended to treat a wide range of oncology indications. The company's product are: HyperAcute Pancreas, HyperAcute Lung, HyperAcute Melanoma, HyperAcute Imunotherapies, NLG8189 and IDO Pathway Inhibitors. NewLink Genetics was founded by Charles J. Link and Nicholas N. Vahanian on June 4, 1999 and is headquartered in Ames, IA.

Contact Information

NewLink Genetics Corp.
2503 South Loop Drive
Ames Iowa 50010
P:(515) 296-5555
Investor Relations:

Employees

Shareholders

Individual stakeholders29.53%
Mutual fund holders28.51%
Other institutional24.13%

Top Executives

Charles J. LinkChairman, Chief Executive & Scientific Officer
Nicholas N. VahanianPresident & Chief Medical Officer
Gordon H. LinkChief Financial Officer & Secretary
W. Jay RamseyClinical & Regulatory Compliance Officer
Brian WileyVice President-Business Development

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.